Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT02233205
Brief Summary:
Ultrasonic sonoporation can increase the release of chemotherapeutics, thus increasing the therapeutic effects. The main purpose is to identify the safety of combining ultrasonic microbubbles and chemotherapeutics to treat malignant neoplasms of hepatic metastases from alimentary system and pancreatic carcinoma.
Detailed Description:
Ultrasonic sonoporation can increase the release of chemotherapeutics, thus increasing the therapeutic effects.
1. Main purpose
1. To identify the safety of combining ultrasonic microbubbles and chemotherapeutics to treat malignant neoplasms of hepatic metastases from alimentary system and pancreatic carcinoma.
2. To explore the largest mechanical index and ultrasonic treatment time which patients can endure.
2. Secondary purpose
1. To observe tumor clinical benefit rate (CR+PR+SD).
2. To evaluate the preliminary effect,such as time to failure(TTF), time to death(TTD)
Study:
NCT02233205
Study Brief:
Protocol Section:
NCT02233205